Cel­tarys Research

Cel­tarys Research is a newly cre­ated com­pany focused on the devel­op­ment of innov­at­ive chem­ical tools that improve High Through­put Screen­ing (HTS) effi­ciency in early drug dis­cov­ery. As a spin-off of the Uni­ver­sity of San­ti­ago de Com­postela, our com­pany sprang from the work of Prof. Eddy Sotelo, Dr. Jhonny Azuaje, and Dr. Maria Majel­laro devel­op­ing a pro­pri­et­ary con­jug­a­tion tech­no­logy that allows fluoro­phores, lig­ands, linkers, or other func­tional mod­ules to be com­bined in a green and effi­cient work­flow. Cel­tarys has suc­cess­fully exploited its pat­ent and now offers a port­fo­lio of >30 fluor­es­cent GPCR lig­ands as well as cus­tom­ized devel­op­ment pro­jects for phar­ma­ceut­ical com­pan­ies, CROs, and aca­demic groups.

Cel­tarys co-founder and CSO Dr. Maria Majel­laro is a Work Pack­age Leader within the Uni­S­ens Pro­ject and pro­motes equal­ity and diversity in our con­sor­tium by tak­ing part in the EIC Women Lead­er­ship Pro­gramme. The Cel­tarys team is com­prised of highly qual­i­fied and motiv­ated medi­cinal and organic chem­ists. These include recent arrivals Dr. Paolo Des­tito (far right in pic­ture below) and Dr. Adrián Robles (far left), both experts in organic chem­istry with high pro­fi­ciency in design­ing and optim­iz­ing syn­thetic strategies. Along with Dr. Maria Majel­laro (second from left) and Prof. Eddy Sotelo (second from right), this team will gen­er­ate innov­at­ive fluor­es­cent reagents required for devel­op­ment of the Uni­S­ens tech­no­logy platform.